On January 12, 2023 Leidos (NYSE: LDOS), a FORTUNE 500 science and technology company, has scheduled a conference call for Tuesday, Feb. 14, 2023, at 8 a.m. (ET) to announce its fourth quarter and full year 2022 financial results for the period ending December 30, 2022 (Press release, Leidos, JAN 12, 2023, View Source [SID1234626207]). The company plans to issue its quarterly earnings press release before the conference call on Feb. 14, 2023.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The details for the earnings conference call follow:

Date: Feb. 14, 2023

Time: 8 a.m. (ET)

To Listen via the Internet:

The company offers a live and replay audio broadcast of the conference call with corresponding press release, presentation materials, and supplemental information at View Source

To Listen via Telephone:

877-869-3847 (toll-free U.S.)

+1-201-689-8261 (for International Callers)

Replay:

A telephone playback of the fourth quarter and full year 2022 earnings conference call is scheduled to be available beginning at 11:30 a.m. (ET) on Feb. 14, 2023, through 11:59 p.m. (ET) on Feb. 21, 2023. The replay will be accessible by calling 877-660-6853 (International callers: +1-201-612-7415) and entering conference ID 13735521.

An archived version of the webcast will be available on the Leidos Investor Relations website at View Source